Other publications - Konstantinos Kamposioras


  1. Papaxoinis G, Kamposioras K, Weaver JMJ, Kordatou Z, Stamatopoulou S, Germetaki T, Nasralla M, Owen-Holt V, Anthoney A, Mansoor W. The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study. J Gastrointest Surg. 2019 Jan 22.
  2. Kamposioras K, Tsimplouli C, Verbeke C, Anthoney A, Daoukopoulou A, Papandreou CN, Sakellaridis N, Vassilopoulos G, Potamianos SP, Liakouli V, Migneco G, Del Galdo F, Dimas K. Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model. Int J Oncol. 2019 Feb;54(2):537-549
  3. 3892/ijo.2018.4640.Sereti E, Karagianellou T, Kotsoni I, Magouliotis D, Kamposioras K, Ulukaya E, Sakellaridis N, Zacharoulis D, Dimas K Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? J Proteomics. 2018 Feb 1. pii: S1874-3919(18)30043-5
  4. Papaxoinis G, Kamposioras K, Germetaki T, Weaver J, Stamatopoulou S, Nasralla M, , Zoe Kordatou Z, Owen-Holt V, Anthoney A, Mansoor W Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy Acta Oncol. 2018 Jun;57(6):790-798. Papadopoulos V, Tsapakidis K, Riobo Del Galdo NA, Papandreou CN, Del Galdo F, Anthoney A, Sakellaridis N, Dimas K, Kamposioras K. The Prognostic Significanc of the Hedgehog Signaling Pathway in Colorectal Cancer. Clin Colorectal Cancer. 2016 Jun;15(2):116-27.
  5. Califano R, Karamouzis MV, Banerjee S, de Azambuja E, Guarneri V, Hutka M, Jordan K, Kamposioras K, Martinelli E, Corral J, Postel-Vinay S, Preusser M, Porcu L, Torri V. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO)young oncologists committee. Lung Cancer. 2014 Jul;85(1):74-80.
  6. Kamposioras K, Anthoney A, Fernández Moro C, Cairns A, Smith AM, Liaskos C,Verbeke CS. Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer. Br J Surg. 2014 Jan;101(2):89-99.
  7. Kamposioras K, Konstantara A, Kotoula V, Lakis S, Kouvatseas G, Akriviadis E, Vrettou E, Dionysopoulos D, Krikelis D, Papadopoulou K, Charalambous E, Chrisafi S, Konstantaras C, Fountzilas G. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival. Anticancer Res. 2013 Oct;33(10):4573-84.
  8. Kamposioras K., Pentheroudakis G., Pavlidis N Exploring the Biology of Cancer of Unknown Primary: breakthroughs and drawbacks. European Journal of Clinical Investigation. 2013 May;43(5):491-500.
  9. Vlachostergios PJ, Gioulbasanis I, Ghosh S, Tsatsanis C, Papatsibas G, Xyrafas A, Hatzidaki E, Vasiliou C, Kamposioras K, Agelaki S, Margioris AN, Nasi D, Georgoulias V, Papandreou CN. Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer. Clin Transl Oncol. 2013 Mar 5.
  10. Vrettos I., Kamposioras K, Peridis S., Aninos D., Kazika S.,  Spathis A., Karakitsios P., Angelos Papadopoulos A. Concurrent pleural infiltration by Chronic Lymphocytic Leukemia and adenocarcinoma of unknown primary site diagnosed by effusion cytology Diagnostic Cytopathology Diagn Cytopathol. 2012 Jul 26
  11. Papatsimpas G, Kamposioras K. , Kallirroi Goula K, Papaparaskeva , Loukides S, Kotoulas C., Kelekis N.e, Nikolaos Xiros N. Pectasides D. Koumarianou A Hepatoid Pancoast tumor. A case report and review of the literature Lung Cancer. 2012 Aug;77(2):239-45
  12. Vrettos I, Kamposioras K, Kontodimopoulos N, Pappa E, Georgiadou E, Haritos D, Papadopoulos AA, Niakas D. Comparing Health-Related Quality of Life of Cancer Patients under Chemotherapy and of Their Caregivers. 2012;2012:135283.
  13. Tzovaras AA, Kamposioras K, Ardavanis A. Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker. Arch Med Sci. 2011 Dec 31;7(6):925-7.
  14. Vlachostergios PJ, Gioulbasanis I, Kamposioras K, Georgoulias P, Baracos VE, Ghosh S, Maragouli E, Georgoulias V, Papandreou CN. Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss and Clinical Outcome in Metastatic Non-Small Cell Lung Cancer Patients. 2011 Oct 4;81(2):113-118.
  15. Apostol I, Baban A, Nicula F, Suteu O, Coza D, Amati C, Baili P; EUROCHIP Working Group. Cervical cancer assessment in Romania under EUROCHIP-2. 2010 Jul-Aug;96(4):545-52.
  16. Valerianova Z, Panayotova Y, Amati C, Baili P; EUROCHIP Working GroupCervical cancer screening in Bulgaria--past and present experience. Tumori. 2010 Jul-Aug;96(4):538-44.
  17. Viberga I, Engele L, Baili P; EUROCHIP Working GroupPast, present and future of the cervical cancer screening in Latvia. 2010 Jul-Aug;96(4):529-37.
  18. Veerus P, Arbyn M, Amati C, Paolo B; EUROCHIP Working Group. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia. Tumori. 2010 Jul-Aug;96(4):524-8
  19. Kamposioras K, Pentheroudakis G., Pectasides D, Pavlidis Malignant Melanoma of Unknown Primary site. To make the long story short. A systematic review of the literature Crit Rev Oncol Hematol. 2010 May 28.
  20. Karampoiki , Alevizaki P., Lakiotis V., Loukidou E., Terzoudi A., Gkinosati A., Panou C., Ioakeimidou A., Kamposioras K., Valachis A., Tsali L., Pantazi E., Koukourakis G., Karathanasi I., Thanopoulou E., Mauri D. Evaluating the strength of potential misplaced priorities in opportunistic cancer screening practice in Greece J BUON. 2010 Jan-Mar;15(1):164-73
  21. Papadopoulos A., Vrettos I., Kamposioras K., Anagnostopoulos F., Giannopoulos G., Pectasides D., Niakas D., Economopoulos T. Impact of cancer patients’ disease awareness on their family members’ health related quality of life (HRQL) A cross-sectional survey 2010 Mar 17. [Epub ahead of print]
  22. Mauri D, Kamposioras K, Tsali L, Bristianou M, Valachis A, Karathanasi I, Georgiou  C, Polyzos NP. Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis. Cancer Treat Rev. 2010 Feb;36(1):69-74.
  23. Koukourakis G., Kouloulias V., Platoni K., Koukourakis M., Maravelis G., Fotineas A., Zacharias G., Kamposioras K., Mauri D., Kelekis N. Results of a five split-field technique of postoperative 3d radiation therapy in patients with gastric adenocarcinoma Cancer Therapy Vol 7, 373-377, 2009
  24. Mauri D, Valachis A, Polyzos IP, Polyzos NP, Kamposioras K, Pesce LL. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. Breast Cancer Res Treat. 2009 Aug;116(3):433-9. Epub 2009 Jun 12.
  25. Pectasides D, Pectasides E, Papaxoinis G, Koumarianou A, Psyrri A, Xiros N, Tountas N, Kamposioras K, Papatsibas G, Floros T, Gouveris P, Karageorgopoulou S, Economopoulos T. Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience. Anticancer Res. 2009 Feb;29(2):769-75.
  26. Mauri, C. Panou, A. Valachis, K. Kamposioras, L. Tsali Tyrosine kinase inhibitors in treatment of fibrous histiocytoma Exp Oncol 2009 31, 1, 1–3
  27. Mauri, A. Valachis, N. P. Polyzos, I. Cortinovis, V. Karampoiki , E. Loukidou, P. Alevizaki, K. Kamposioras, G. Kouris, P.Alexandropoulou, L. Tsali, C. Panou, A. Stamatelopoulos, V. Lakiotis, A. Spiliopoulou, A.Terzoudi, A. Ioakimidou, I. Karathanasi, M. Bristianou, G. Casazz, N. Pavlidis Screening practice and misplaced priorities Clinical and Translational Oncology (accepted)
  28. Mauri D, Karampoiki V, Mauri J, Kamposioras K, Alexiou G, Ferentinos G, Tsali L, Karathanasi I, Peponi C; SESy_Europe Task Force.  Double-blind control of the data manager doesn't have any impact on data entry reliability and should be considered as an avoidable cost. BMC Med Res Methodol. 2008 Oct 20;8:66.
  29. Karathanasi I, Kamposioras K, Cortinovis I, Karampoiki V, Alevizaki P, Dambrosio M, Zorba E, Panou C, Pantazi E, Bristianou M, Kouiroukidou P, Bouiatiotis E, Xilomenos A, Zavou D, Casazza G, Mauri D; PACMeR. Moving ahead in diabetics' cancer screening; food for thought from the Hellenic experience. Eur J Cancer Care (Engl). 2009 Jan 23.
  30. Pectasides D, Pectasides E, Papaxoinis G, Skondra M, Gerostathou M, Karageorgopoulou S, Kamposioras C, Tountas N, Koumarianou A, Psyrri A, Macheras A, Economopoulos T. Testicular Function in Poor-Risk Nonseminomatous Germ Cell Tumors Treated with Methotrexate, Paclitaxel, Ifosfamide, and Cisplatin Combination Chemotherapy J Androl. 2009 Jan 8. [Epub ahead of print]
  31. Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Kamposioras K, Tountas N, Economopoulos T. Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors. Urol Oncol. 2008 Dec 24. [Epub ahead of print]
  32. Kamposioras K, Mauri D, Alevizaki P, Ferentinos G, Karampoiki V, Kouiroukidou P, Zorba E, Proiskos A, Chasioti D, Panou C, Gkinosati A, Chatziioannou I, Aggelinas G, Xilomenos A. Cancer screening in Greece. Guideline awareness and prescription behavior among Hellenic physicians. Eur J Intern Med. 2008 Oct;19(6):452-60
  33. Pectasides D, Kamposioras K, Papaxoinis G, Papachristodoulou . Pectasides E. Chemotherapy for recurrent cervical cancer Cancer Treat Rev. 2008 Nov;34(7):603-13.
  34. Zacharias G, Xilomenos A, Koukourakis G, Kamposioras K, Mauri D, Chasioti D, Bristianou M, Ferentinos G, Levantakis I, Tsali L, Valachis A, Karampoiki V. Responsibilities in cancer preventive care in Greece. A physicians' survey Clin Transl Oncol. 2008 Apr;10(4):231-4.
  35. Kamposioras K, Mauri D, Valachis A, Tsali L, Polyzos NP. Low colorectal cancer screening rates and primary care physicians' behavior. Am J Gastroenterol. 2008 Mar;103(3):804-5.
  36. Briasoulis E, Kamposioras K, Tzovaras V, Pafitanis G, Kostoula A, Mavridis A, Pavlidis N. CENP-B specific anti-centromere autoantibodies heralding small cell lung cancer. A case study and review of the literature Lung Cancer. 2008 May;60(2):302-6.
  37. Kamposioras K, Pentheroudakis G, Malamou-Mitsi V, Pappa L, Bafa M, Pavlidis N. Can circulated lung cancer cells pass to the urine without apparent urine tract metastases? A single centre series Lung Cancer. 2008 Apr;60(1):141-5
  38. Karampoiki V, Flores FJ, Altinoz H, Chojnacka M, Karentzou I, Dambrosio M, Colichi C, Oxiuzova T, Kanavoura E, de Sousa BA, Ivanova D, Mauri J, Alexiou G, Mauri D, Kamposioras K, Maragkaki A, Peponi C. Screening Evaluation System – Europe met skin cancer screening Cent Eur J Public Health 2007; 15 (1): 66–68
  39. Kamposioras K, Mauri D, Tsekoura P, Valachis A, Tsappi M, Polyzos N Impact of chest radiography screening on healthcare spending Am J Manag Care. 2007; 13, 218-219
  40. Polyzos NP, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I, Casazza G. Combined Vitamin C and E Supplementation During Pregnancy For Preeclampsia Prevention: A Systematic Review. Obstet Gynecol Surv. 2007 Mar;62(3):202-206.
  41. Pazarlis P, Mauri D, Cortinovis I, Katsigiannopoulos K, Alevizaki P, Koukourakis G, Casazza G, Kamposioras K, Chatziioannou I, Milousis A, Papakonstantinou A, Karathanasi I, Alexiou G, Proiskos A, Mitrogianni Z, Peponi C. Socio-demographic status and alcohol drinking patterns among Greek healthy adults. Cent Eur J Public Health. 2006 Dec;14(4):160-7.
  42. Mauri, K. Kamposioras, Ν.P. Polyzos, F. J. Rivas Flores, H. Altinoz, M. Chojnacka, I. Karentzou, M. Dambrosio, C. Colich, , T. Oxiuzova, E. Kanavoura8, B. A. M. da Silva Αlves deSousa, D. Ivanova, J. Mauri, V.Karampoiki, A. Maragkaki, A. Xilomenos Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force Exp Oncol. 2006 Sep;28(3):252-3.
  43. Mauri D, Kamposioras K, Proiskos A, Xilomenos A, Peponi C, Dambrosio M, Zacharias G, Koukourakis G, Pentheroudakis G, Pavlidis N. Old Habits Die Hard: Chest Radiography for Screening Purpose in Primary Care Am J Manag Care. 2006;12:650-656
  44. Polyzos NP, Vittoraki A, Tsappi M, Mauri D, Spiliopoulou A, Tzioras S, Kamposioras K, Ioakeimidou A. Food for Thought in Women’s health. Gynecologist: New European Gatekeeper in Chlamydia Trachomatis infection Acta Obstet Gynecol Scand. 2006;85(10):1156-9.
  45. Kamposioras K, Mauri D, Golfinopoulos V, Ferentinos G, Zacharias G, Xilomenos A,  Polyzos P. N, Bristianou M, Chasioti D, Milousis A, Vittoraki A, Koukourakis G, Chatziioannou I, Papadopoulos P. Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration. Int J Colorectal Dis. 2007 May;22(5):475-81
  46. Elefsiniotis IS, Vezali E, Kamposioras K, Pantazis KD, Tontorova R, Ketikoglou I, Moulakakis A, Saroglou G. Immunogenicity of recombinant hepatitis b vaccine in treatment-naïve and treatment-experienced chronic hepatitis c patientsthe effect of pegylated Interferon plus ribavirin treatment World J Gastroenterol 2006 July 21; 12(27): 4420-4424
  47. Xilomenos A, Mauri D, Kamposioras K, Gkinosati A, Zacharias G, Sidiropoulou V, Papadopoulos P, Chatzimichalis G, Golfinopoulos V, Peponi C, Pacmer PAColorectal cancer screening awareness among physicians in Greece. BMC Gastroenterol. 2006 Jun 6; 6:18.
  48. Kamposioras K, Casazza G, Mauri D, Lakiotis V, Cortinovis I, Xilomenos A, Peponi C, Golfinopoulos V, Milousis A, Kakaridis D, Zacharias G, Karathanasi I, Ferentinos G, Proiskos A, Panhellenic Association For Continual Medical Research. Screening chest radiography results from a Greek cross-sectional survey. BMC Public Health. 2006 Apr 29;6:113.
  49. Proiskos A, Loukidou E, Kamposioras K, Bristianou M, Zina V, Pliadi O, Karakatsanis A, Alexiou G, Gkougkoutsi A, Mauri D. Screening chest radiography in Primary Care: an underestimate belief Eur J Gen Pract. 2005 Jun;11(2):76-7


  1. P. Polyzos, S. Tzioras, D. Mauri, M. Tsappi, A. Valachis, C. Dritsas, K. Kamposioras C. Panou, L. Tsali Chapter,Aromatase Inhibitors in Ovulation Induction: Myth or Reality? Aromatase Inhibitors: Types, Mode of Action and Indications Editor: J. R. Lamonte, Novapublishers
  2. Kamposioras and E. Briasoulis Chapter: Hormonotherapy of bone metastases BONE METASTASES: A TRANSLATIONAL AND CLINICAL APPROACH Editors: Dimitrios Kardamakis, Edward Chow, Vassilios Vassiliou Publisher Springer (The Netherlands) (2014)
  3. Mauri D, Kamposioras K, Valachis A, Polyzos NP, Lakiotis V, Proiskos A, Tsekoura P, Koukourakis G, Xilomenos A, Zacharias G, Karampoiki V, Karathanasi I, Spiliopoulou A. “European vsNorth American cancer screening attitude and practices in primary careA systematic review and a critical appraisal for the implementation of evidence based and non evidence based tests”. in “Health Knowledge, Attitudes, and Practices.” Editors: Patricia I. Eddington and Umberto V. Mastolli, Novapublishers, New York. [Chapter commissioned by invitation by the Editor on March 29, 2007].
  4. Andrea Micheli, Paolo Baili and EUROCHIP-2 Working Chapter 9 Group Information on cancer in Responding to the challenge of cancer in Europe by Michel P Coleman, Delia-Marina Alexe, Tit AlbrehtMartin McKee

Last updated: January 2023